BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 12488556)

  • 1. Bryostatin 1 and UCN-01 potentiate 1-beta-D-arabinofuranosylcytosine-induced apoptosis in human myeloid leukemia cells through disparate mechanisms.
    Wang S; Wang Z; Grant S
    Mol Pharmacol; 2003 Jan; 63(1):232-42. PubMed ID: 12488556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of tumor necrosis factor by bryostatin 1 is involved in synergistic interactions with paclitaxel in human myeloid leukemia cells.
    Wang S; Wang Z; Dent P; Grant S
    Blood; 2003 May; 101(9):3648-57. PubMed ID: 12522001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Agents that down-regulate or inhibit protein kinase C circumvent resistance to 1-beta-D-arabinofuranosylcytosine-induced apoptosis in human leukemia cells that overexpress Bcl-2.
    Wang S; Vrana JA; Bartimole TM; Freemerman AJ; Jarvis WD; Kramer LB; Krystal G; Dent P; Grant S
    Mol Pharmacol; 1997 Dec; 52(6):1000-9. PubMed ID: 9396780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bryostatin 1 increases 1-beta-D-arabinofuranosylcytosine-induced cytochrome c release and apoptosis in human leukemia cells ectopically expressing Bcl-x(L).
    Wang Z; Wang S; Dai Y; Grant S
    J Pharmacol Exp Ther; 2002 May; 301(2):568-77. PubMed ID: 11961058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentiation of 1-beta-D-arabinofuranosylcytosine-mediated mitochondrial damage and apoptosis in human leukemia cells (U937) overexpressing bcl-2 by the kinase inhibitor 7-hydroxystaurosporine (UCN-01).
    Tang L; Boise LH; Dent P; Grant S
    Biochem Pharmacol; 2000 Nov; 60(10):1445-56. PubMed ID: 11020446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiation of ara-C-induced apoptosis by the protein kinase C activator bryostatin 1 in human leukemia cells (HL-60) involves a process dependent upon c-Myc.
    Chelliah J; Freemerman AJ; Wu-Pong S; Jarvis WD; Grant S
    Biochem Pharmacol; 1997 Sep; 54(5):563-73. PubMed ID: 9337072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of protein kinase C activity and calcium-sensitive isoform expression in human myeloid leukemia cells by bryostatin 1: relationship to differentiation and ara-C-induced apoptosis.
    Grant S; Turner AJ; Freemerman AJ; Wang Z; Kramer L; Jarvis WD
    Exp Cell Res; 1996 Oct; 228(1):65-75. PubMed ID: 8892972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein kinase C-dependent activation of the tumor necrosis factor receptor-mediated extrinsic cell death pathway underlies enhanced apoptosis in human myeloid leukemia cells exposed to bryostatin 1 and flavopiridol.
    Cartee L; Maggio SC; Smith R; Sankala HM; Dent P; Grant S
    Mol Cancer Ther; 2003 Jan; 2(1):83-93. PubMed ID: 12533676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions between 2-fluoroadenine 9-beta-D-arabinofuranoside and the kinase inhibitor UCN-01 in human leukemia and lymphoma cells.
    Harvey S; Decker R; Dai Y; Schaefer G; Tang L; Kramer L; Dent P; Grant S
    Clin Cancer Res; 2001 Feb; 7(2):320-30. PubMed ID: 11234887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potentiation of the activity of 1-beta-D-arabinofuranosylcytosine by the protein kinase C activator bryostatin 1 in HL-60 cells: association with enhanced fragmentation of mature DNA.
    Grant S; Jarvis WD; Swerdlow PS; Turner AJ; Traylor RS; Wallace HJ; Lin PS; Pettit GR; Gewirtz DA
    Cancer Res; 1992 Nov; 52(22):6270-8. PubMed ID: 1423273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein kinase C activation modulates pro- and anti-apoptotic signaling pathways.
    Meinhardt G; Roth J; Totok G
    Eur J Cell Biol; 2000 Nov; 79(11):824-33. PubMed ID: 11139146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of bryostatin 1 and other pharmacological activators of protein kinase C on 1-[beta-D-arabinofuranosyl]cytosine-induced apoptosis in HL-60 human promyelocytic leukemia cells.
    Jarvis WD; Povirk LF; Turner AJ; Traylor RS; Gewirtz DA; Pettit GR; Grant S
    Biochem Pharmacol; 1994 Mar; 47(5):839-52. PubMed ID: 8135859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of bryostatin 1 and calcium ionophore (A23187) on apoptosis and differentiation in human myeloid leukemia cells (HL-60) following 1-beta-D-arabinofuranosylcytosine exposure.
    Vrana JA; Rao AS; Wang Z; Jarvis WD; Grant S
    Int J Oncol; 1998 Apr; 12(4):927-34. PubMed ID: 9499457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of AS101 on bryostatin 1-mediated differentiation induction, cell cycle arrest, and modulation of drug-induced apoptosis in human myeloid leukemia cells.
    Rao AS; Freemerman AJ; Jarvis WD; Chelliah J; Bear HD; Mikkelsen R; Grant S
    Leukemia; 1996 Jul; 10(7):1150-8. PubMed ID: 8683995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for involvement of mitogen-activated protein kinase, rather than stress-activated protein kinase, in potentiation of 1-beta-D-arabinofuranosylcytosine-induced apoptosis by interruption of protein kinase C signaling.
    Jarvis WD; Fornari FA; Tombes RM; Erukulla RK; Bittman R; Schwartz GK; Dent P; Grant S
    Mol Pharmacol; 1998 Nov; 54(5):844-56. PubMed ID: 9804619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro effects of bryostatin 1 on the metabolism and cytotoxicity of 1-beta-D-arabinofuranosylcytosine in human leukemia cells.
    Grant S; Boise L; Westin E; Howe C; Pettit GR; Turner A; McCrady C
    Biochem Pharmacol; 1991 Jul; 42(4):853-67. PubMed ID: 1867641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapamycin and UCN-01 synergistically induce apoptosis in human leukemia cells through a process that is regulated by the Raf-1/MEK/ERK, Akt, and JNK signal transduction pathways.
    Hahn M; Li W; Yu C; Rahmani M; Dent P; Grant S
    Mol Cancer Ther; 2005 Mar; 4(3):457-70. PubMed ID: 15767555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Farnesyltransferase inhibitors interact synergistically with the Chk1 inhibitor UCN-01 to induce apoptosis in human leukemia cells through interruption of both Akt and MEK/ERK pathways and activation of SEK1/JNK.
    Dai Y; Rahmani M; Pei XY; Khanna P; Han SI; Mitchell C; Dent P; Grant S
    Blood; 2005 Feb; 105(4):1706-16. PubMed ID: 15494423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bryostatin 1 enhances paclitaxel-induced mitochondrial dysfunction and apoptosis in human leukemia cells (U937) ectopically expressing Bcl-xL.
    Wang S; Wang Z; Boise LH; Dent P; Grant S
    Leukemia; 1999 Oct; 13(10):1564-73. PubMed ID: 10516758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. UCN-01 (7-hydroxystauorsporine) blocks PMA-induced maturation and reciprocally promotes apoptosis in human myelomonocytic leukemia cells (U937).
    Rahmani M; Grant S
    Cell Cycle; 2002; 1(4):273-81. PubMed ID: 12429947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.